As Per the Report, the Size of the North America Surgical Lasers Market is valued at 0.75 billion in 2023 and is expected to reach 0.92 billion by 2028, growing at a CAGR of 4.10 % during the forecast period 2023 to 2028.
The increasing prevalence of chronic diseases and other targeted diseases are primarily driving the surgical lasers market in North America. Also, Y-O-Y increasing ophthalmic disorders are boosting the market growth.
On the other hand, the growing preference for minimally invasive surgeries increases the demand for the market. In addition, the technological advancement in surgical lasers expanding the adoption of applications, such as ophthalmology, dermatology, and dentistry, are uplifting the market growth.
The growing senior population contributes to the market growth significantly. However, the increasing population and the associated lifestyle disorders further boost the market growth.
Furthermore, because of lasers' unique ability to target specific structures and layers of tissues, surgical lasers are an important tool in cosmetic and reconstructive surgery. According to the American Society of Plastic Surgeons, surgical and nonsurgical cosmetic procedures in the U.S. have grown over the last decade. Over 4.6 million aesthetic minimally invasive treatments were conducted in 2020. It is estimated to reach its number during the forecast period; therefore, these factors are expected to expand the regional market growth.
However, the emerging countries in the region, such as the United States and Canada, are offering significant growth opportunities to the market player due to the advancing healthcare sector and the presence of key market players.
Increasing investments by the leading market players, government and non-government organizations in research and development activities, and infrastructure development encourage market growth.
Surgical lasers are expected to see significant growth in urology in the coming years, owing to the rising prevalence of urology problems such as renal cancer, prostate enlargement, kidney stones, growing patient knowledge, and significantly increasing demand for minimally invasive urological surgeries.
However, the high cost of procedures associated with laser surgery is expected to hinder the market growth. Also, stringent regulations regarding the approval of surgical lasers are likely to limit the market growth.
This research report on the North America Surgical Lasers Market has been segmented and sub-segmented into the following categories.
By Procedure Type:
Geographically, North America is the major region for the Surgical lasers market in terms of growth. The market held the largest share over the forecast period, and it is more likely to continue its expansion throughout the period. The market growth is fueled by the high prevalence of targeted diseases, chronic diseases, and the advanced healthcare sector. In addition, the availability of well-established healthcare infrastructure, key market players, mergers, collaboration, and favorable reimbursement policies further contribute to the market growth.
The U.S Surgical lasers market is more likely to witness a significant share in the market during the forecast period. Technological advancements, growing awareness, and the high prevalence rate of diseases fuel market growth. Moreover, the growing demand for aesthetic and cosmetic procedures,
The Canada Surgical lasers market is anticipated to account for a significant share in the market owing to the prevalence of cardiovascular diseases, initiatives taken by the government, increasing investments, presence of local players, and increasing demand for minimally invasive or non-invasive procedures are boosting the market growth.
KEY MARKET PLAYERS
Promising Companies dominating the North America Surgical Lasers Market Profiled in the Report are Lumenis (Israel), Alma Lasers (Israel), Cynosure, IPG Photonics Corporation (U.S.), Inc. (U.S.), Boston Scientific Corporation (U.S.), Abbott Laboratories, Spectranetics Corporation (U.S.), Fotona d.o.o. (Slovenia), Biolitec AG (Austria) and BISON MEDICAL Co., Ltd. (South Korea).,
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: firstname.lastname@example.org